A federally funded effort to identify high-risk patients and coordinate their care is delivering modest savings, but significant cost reductions may come only after broader payment reforms take hold.
A federally funded effort to identify high-risk patients and coordinate their care is delivering modest savings, but significant cost reductions may come only after broader payment reforms take hold.
The “medical neighborhood” demonstration is generating savings of about 5%, which may not be enough to yield a return on investment for providers, according to preliminary findings shared by Dr. Bruce Bagley, president and CEO of TransforMED. “And that's a problem,” Bagley said, speaking at the American College of Physician Executives annual meeting in Chicago.
TransforMED, a consulting subsidiary of the American Association of Family Physicians dedicated to patient-centered medical homes, is carrying out the experiment with a $20.75 million grant from the CMS Innovation Center, and Bagley cautioned that the CMS had not yet certified the numbers.
Read the full story here: http://bit.ly/1lubXJf
Source: Modern Healthcare
Specialty Drug Costs Drive Medicare Part D Dermatology Expenditures
July 22nd 2025The rapidly increasing prescriptions for expensive specialty medications, rather than their price growth, are the primary driver of escalating dermatology Medicare Part D expenditures, necessitating policies that balance innovation, access, and affordability.
Read More